{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:13:28Z","timestamp":1792588408121,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013528","name":"DC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.antiviral.2019.104703","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T08:49:00Z","timestamp":1578646140000},"page":"104703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination"],"prefix":"10.1016","volume":"174","author":[{"given":"Elizabeth C.","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B.","family":"Bradfute","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104703_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.104703_bib2","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.4049\/jimmunol.176.8.4525","article-title":"Cutting edge: CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion","volume":"176","author":"Aichele","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib3","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1128\/JVI.78.8.4323-4329.2004","article-title":"Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus","volume":"78","author":"Andersson","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/jmv.21222","article-title":"Crimean\u2010Congo hemorrhagic fever virus delays activation of the innate immune response","volume":"80","author":"Andersson","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jmv.20530","article-title":"Type I interferon inhibits Crimean\u2010Congo hemorrhagic fever virus in human target cells","volume":"78","author":"Andersson","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1084\/jem.183.5.2391","article-title":"Interferon gamma production by natural killer (NK) cells and NK1. 1+ T cells upon NKR-P1 cross-linking","volume":"183","author":"Arase","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.104703_bib7","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1128\/JVI.02188-08","article-title":"NS5 of dengue virus mediates STAT2 binding and degradation","volume":"83","author":"Ashour","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002916","article-title":"Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism","volume":"8","author":"Bale","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104703_bib9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/jir.2009.0076","article-title":"Evasion of interferon responses by Ebola and Marburg viruses","volume":"29","author":"Basler","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2019.104703_bib10","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","article-title":"The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3","volume":"77","author":"Basler","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib11","doi-asserted-by":"crossref","first-page":"12289","DOI":"10.1073\/pnas.220398297","article-title":"The Ebola virus VP35 protein functions as a type I IFN antagonist","volume":"97","author":"Basler","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104703_bib12","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib13","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.3390\/v2112443","article-title":"Inhibition of the type I interferon antiviral response during arenavirus infection","volume":"2","author":"Borrow","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104703_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137786","article-title":"Human polyclonal antibodies produced through DNA vaccination of transchromosomal cattle provide mice with post-exposure protection against lethal zaire and Sudan ebolaviruses","volume":"10","author":"Bounds","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104703_bib15","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1128\/JVI.02199-05","article-title":"Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling","volume":"80","author":"C\u00e1rdenas","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib16","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1099\/jgv.0.000280","article-title":"Suppression of type I and type III IFN signalling by NSs protein of severe fever with thrombocytopenia syndrome virus through inhibition of STAT1 phosphorylation and activation","volume":"96","author":"Chaudhary","year":"2015","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib17","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1021\/cb5006454","article-title":"Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge","volume":"9","author":"Chen","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.antiviral.2019.104703_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4049\/jimmunol.136.3.949","article-title":"AT cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma","volume":"136","author":"Coffman","year":"1986","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.virusres.2011.11.002","article-title":"The generation of a reverse genetics system for Kyasanur Forest Disease Virus and the ability to antagonize the induction of the antiviral state in vitro","volume":"163","author":"Cook","year":"2012","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.104703_bib21","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.4049\/jimmunol.176.7.4343","article-title":"Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection","volume":"176","author":"Coro","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib22","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1073\/pnas.94.2.634","article-title":"Interferon-\u03b1\/\u03b2 inhibition of interleukin 12 and interferon-\u03b3 production in vitro and endogenously during viral infection","volume":"94","author":"Cousens","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104703_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nri3806","article-title":"Regulation of antiviral T cell responses by type I interferons","volume":"15","author":"Crouse","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib24","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.8456300","article-title":"Multiple defects of immune cell function in mice with disrupted interferon-gamma genes","volume":"259","author":"Dalton","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib25","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1038\/mt.2016.161","article-title":"Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses","volume":"24","author":"De Beuckelaer","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.antiviral.2019.104703_bib26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1189\/jlb.69.6.912","article-title":"Functional classification of interferon\u2010stimulated genes identified using microarrays","volume":"69","author":"De Veer","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2019.104703_bib27","doi-asserted-by":"crossref","first-page":"15623","DOI":"10.1073\/pnas.95.26.15623","article-title":"Identification of genes differentially regulated by interferon \u03b1, \u03b2, or \u03b3 using oligonucleotide arrays","volume":"95","author":"Der","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104703_bib28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1128\/jvi.2.10.955-961.1968","article-title":"Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero)","volume":"2","author":"Desmyter","year":"1968","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib29","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1440-1711.2003.01157.x","article-title":"Evasion of innate and adaptive immunity by flaviviruses","volume":"81","author":"Diamond","year":"2003","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104703_bib30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4049\/jimmunol.174.1.99","article-title":"Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells","volume":"174","author":"Dikopoulos","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000913","article-title":"The great escape: viral strategies to counter BST-2\/tetherin","volume":"6","author":"Douglas","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104703_bib32","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0092-8674(00)81289-1","article-title":"Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease","volume":"84","author":"Durbin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.104703_bib33","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.4049\/jimmunol.163.8.4109","article-title":"Cutting edge: differentiation of antitumor CTL in vivo requires host expression of Stat1","volume":"163","author":"Fallarino","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib34","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1128\/JVI.01362-09","article-title":"Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction","volume":"84","author":"Fan","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.virol.2008.09.019","article-title":"Interferon-beta expressed by a rabies virus-based HIV-1 vaccine vector serves as a molecular adjuvant and decreases pathogenicity","volume":"382","author":"Faul","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104703_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virol.2015.07.010","article-title":"Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells","volume":"485","author":"Feagins","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104703_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1128\/JVI.01006-06","article-title":"The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR","volume":"81","author":"Feng","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib38","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.140.4.1022","article-title":"IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses","volume":"140","author":"Finkelman","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib39","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1002\/eji.201040453","article-title":"Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion","volume":"40","author":"Frenz","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib40","series-title":"Ovarian Tumor Domain-Containing Viral Proteases Evade Ubiquitin-And ISG15-dependent Innate Immune Responses","author":"Garcia-Sastre","year":"2007"},{"key":"10.1016\/j.antiviral.2019.104703_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005908","article-title":"A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models","volume":"11","author":"Garrison","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104703_bib42","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20041964","article-title":"A type I interferon autocrine\u2013paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells","volume":"201","author":"Gautier","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.104703_bib43","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.chom.2016.05.009","article-title":"Zika virus targets human STAT2 to inhibit type I interferon signaling","volume":"19","author":"Grant","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104703_bib101","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.intimp.2017.06.016","article-title":"Activation of IRF3 contributes to IFN-gamma and ISG54 expression during the immune response to B16F10 tumor growth","volume":"50","author":"Petro","year":"2017","journal-title":"Int. immunopharmacol."},{"key":"10.1016\/j.antiviral.2019.104703_bib44","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib45","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1128\/jvi.69.4.2596-2601.1995","article-title":"Tick-borne thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1","volume":"69","author":"Haller","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1034\/j.1600-0897.2001.d01-34.x","article-title":"Protective vaccination against genital herpes simplex virus type 2 (HSV-2) infection in mice is associated with a rapid induction of local IFN-gamma-dependent RANTES production following a vaginal viral challenge","volume":"46","author":"Harandi","year":"2001","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028594","article-title":"Inhibition of interferon induction and action by the nairovirus Nairobi sheep disease virus\/Ganjam virus","volume":"6","author":"Holzer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104703_bib48","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.celrep.2016.04.026","article-title":"Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site","volume":"15","author":"Howell","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2019.104703_bib49","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib50","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1126\/science.8456301","article-title":"Immune response in mice that lack the interferon-gamma receptor","volume":"259","author":"Huang","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib51","doi-asserted-by":"crossref","first-page":"39477","DOI":"10.1074\/jbc.M305038200","article-title":"Viral stress inducible protein P56 inhibits translation by blocking the interaction of eIF3 with the ternary complex (eIF2GTPMet-tRNAi)","volume":"278","author":"Hui","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104703_bib52","doi-asserted-by":"crossref","first-page":"7567","DOI":"10.1128\/JVI.00924-15","article-title":"Different temporal effects of Ebola virus VP35 and VP24 proteins on global gene expression in human dendritic cells","volume":"89","author":"Ilinykh","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib54","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/jmv.20948","article-title":"Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon\u2010beta promoter","volume":"79","author":"J\u00e4\u00e4skel\u00e4inen","year":"2007","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-422X-5-3","article-title":"Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF","volume":"5","author":"J\u00e4\u00e4skel\u00e4inen","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.104703_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nri3254","article-title":"Cross-presentation by dendritic cells","volume":"12","author":"Joffre","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib57","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1128\/JVI.02211-08","article-title":"Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin","volume":"83","author":"Jouvenet","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0167-5699(99)01547-9","article-title":"T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal","volume":"20","author":"Kali\u0144ski","year":"1999","journal-title":"Immunol. today"},{"key":"10.1016\/j.antiviral.2019.104703_bib59","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.4049\/jimmunol.153.11.4948","article-title":"Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2","volume":"153","author":"Kawano","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479","author":"Kell","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104703_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/541984","article-title":"New insights into the function of the immunoproteasome in immune and nonimmune cells","volume":"2015","author":"Kimura","year":"2015","journal-title":"Journal of immunology research"},{"key":"10.1016\/j.antiviral.2019.104703_bib62","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1073\/pnas.76.4.1824","article-title":"Fibroblast interferon induces synthesis of four proteins in human fibroblast cells","volume":"76","author":"Knight","year":"1979","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104703_bib63","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.chom.2014.07.015","article-title":"The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon","volume":"16","author":"Laurent-Rolle","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104703_bib64","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.104703_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0952-7915(02)00354-0","article-title":"Links between innate and adaptive immunity via type I interferon","volume":"14","author":"Le Bon","year":"2002","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib66","article-title":"Mice deficient in interferon-gamma or interferon-gamma receptor 1 have distinct inflammatory responses to acute viral encephalomyelitis","volume":"8","author":"Lee","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104703_bib67","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/jvi.63.6.2813-2819.1989","article-title":"Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice","volume":"63","author":"Leist","year":"1989","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib68","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.02349-05","article-title":"Ebola virus VP24 binds karyopherin \u03b11 and blocks STAT1 nuclear accumulation","volume":"80","author":"Leung","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib69","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1128\/JVI.00916-10","article-title":"Antagonism of type I interferon responses by new world hantaviruses","volume":"84","author":"Levine","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib70","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.immuni.2012.11.005","article-title":"Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol","volume":"38","author":"Liu","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.104703_bib71","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.1114981109","article-title":"Systematic identification of type I and type II interferon-induced antiviral factors","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104703_bib72","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1128\/JVI.80.5.2396-2404.2006","article-title":"A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha\/beta interferon induction and attenuates virus virulence in mice","volume":"80","author":"Liu","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib73","first-page":"27","article-title":"Effectiveness of virazol, realdiron and interferon inductors in experimental Omsk hemorrhagic fever","volume":"47","author":"Loginova","year":"2002","journal-title":"Vopr. Virusol."},{"key":"10.1016\/j.antiviral.2019.104703_bib74","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1128\/JVI.02636-09","article-title":"Ebola virus glycoprotein counteracts BST-2\/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal","volume":"84","author":"Lopez","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006031","article-title":"The Ebola interferon inhibiting domains attenuate and dysregulate cell-mediated immune responses","volume":"12","author":"Lubaki","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104703_bib76","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chom.2015.06.007","article-title":"Flavivirus antagonism of type I interferon signaling reveals prolidase as a regulator of IFNAR1 surface expression","volume":"18","author":"Lubick","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104703_bib77","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1440-1711.2003.01166.x","article-title":"Infection of mouse neurones by West Nile virus is modulated by the interferon\u2010inducible 2\u2032\u20105\u2032 oligoadenylate synthetase 1b protein","volume":"81","author":"Lucas","year":"2003","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104703_bib78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chom.2007.09.003","article-title":"Cholesterol manipulation by West Nile virus perturbs the cellular immune response","volume":"2","author":"Mackenzie","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104703_bib79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.virusres.2013.12.041","article-title":"Hantavirus interferon regulation and virulence determinants","volume":"187","author":"Mackow","year":"2014","journal-title":"Virus Res."},{"key":"10.1016\/j.antiviral.2019.104703_bib80","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ni1138","article-title":"Induced recruitment of NK cells to lymph nodes provides IFN-\u03b3 for T H 1 priming","volume":"5","author":"Mart\u00edn-Fontecha","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib81","doi-asserted-by":"crossref","first-page":"12696","DOI":"10.1128\/JVI.00882-07","article-title":"Differential inhibition of type I interferon induction by arenavirus nucleoproteins","volume":"81","author":"Mart\u00ednez-Sobrido","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib82","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/524024","article-title":"Hantavirus regulation of type I interferon responses","volume":"2012","author":"Matthys","year":"2012","journal-title":"Advances in Virology"},{"key":"10.1016\/j.antiviral.2019.104703_bib83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib84","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4049\/jimmunol.160.9.4298","article-title":"Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development","volume":"160","author":"McRae","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib85","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1002\/hep.25908","article-title":"Identification of type I and type II interferon\u2010induced effectors controlling hepatitis C virus replication","volume":"56","author":"Metz","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2019.104703_bib86","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/IAI.66.2.594-602.1998","article-title":"A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis","volume":"66","author":"Mills","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.antiviral.2019.104703_bib91","doi-asserted-by":"crossref","first-page":"e00151","DOI":"10.1128\/JVI.00151-19","article-title":"Host-specific NS5 ubiquitination determines yellow fever virus tropism","volume":"93","author":"Miorin","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib87","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2017.05.146","article-title":"Antagonism of type I interferon by flaviviruses","volume":"492","author":"Miorin","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2019.104703_bib88","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S1074-7613(03)00264-4","article-title":"Natural killer cells activated by MHC class Ilow targets prime dendritic cells to induce protective CD8 T cell responses","volume":"19","author":"Mocikat","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2019.104703_bib89","doi-asserted-by":"crossref","first-page":"17292","DOI":"10.1073\/pnas.1004879107","article-title":"IFN-\u03b3 produced by CD8 T cells induces T-bet\u2013dependent and\u2013independent class switching in B cells in responses to alum-precipitated protein vaccine","volume":"107","author":"Mohr","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104703_bib90","doi-asserted-by":"crossref","first-page":"e00148","DOI":"10.1128\/JVI.00148-19","article-title":"Comparison of the innate immune response to pathogenic and non-pathogenic Clade B New World arenaviruses","volume":"93","author":"Moreno","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib92","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1126\/science.8009221","article-title":"Functional role of type I and type II interferons in antiviral defense","volume":"264","author":"Muller","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib93","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses","volume":"79","author":"Munoz-Jord\u00e1n","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib94","doi-asserted-by":"crossref","first-page":"14333","DOI":"10.1073\/pnas.2335168100","article-title":"Inhibition of interferon signaling by dengue virus","volume":"100","author":"Mu\u00f1oz-Jord\u00e1n","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2019.104703_bib95","first-page":"1600522","article-title":"Cutting edge: IL-4, IL-21, and IFN-\u03b3 interact to govern T-bet and CD11c expression in TLR-activated B cells","author":"Naradikian","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib96","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.antiviral.2014.02.014","article-title":"Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model","volume":"105","author":"Oestereich","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104703_bib97","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-\u03b3 production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104703_bib98","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1189\/jlb.71.4.669","article-title":"IFN\u2010\u03b12a induces IP\u201010\/CXCL10 and MIG\/CXCL9 production in monocyte\u2010derived dendritic cells and enhances their capacity to attract and stimulate CD8+ effector T cells","volume":"71","author":"Padovan","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2019.104703_bib99","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.7618088","article-title":"Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells","volume":"269","author":"Pernis","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2004.00204.x","article-title":"Interferons, interferon\u2010like cytokines, and their receptors","volume":"202","author":"Pestka","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.antiviral.2019.104703_bib102","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.1132998","article-title":"RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates","volume":"314","author":"Pichlmair","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002407","article-title":"A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection","volume":"7","author":"Pinto","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104703_bib104","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nri1604","article-title":"Mechanisms of type-I-and type-II-interferon-mediated signalling","volume":"5","author":"Platanias","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib105","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1128\/JVI.74.9.3996-4003.2000","article-title":"The role of alpha\/beta and gamma interferons in development of immunity to influenza A virus in mice","volume":"74","author":"Price","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib106","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1128\/JVI.01875-08","article-title":"Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKK\u03b5 and TBK-1","volume":"83","author":"Prins","year":"2009","journal-title":"J. Virol."},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2019.104703_bib107","doi-asserted-by":"crossref","first-page":"S986","DOI":"10.1093\/infdis\/jir335","article-title":"Filovirus infection of STAT-1 knockout mice","volume":"204","author":"Raymond","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104703_bib108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0167-5699(00)01712-6","article-title":"Transcriptional regulation of Th1\/Th2 polarization","volume":"21","author":"Rengarajan","year":"2000","journal-title":"Immunol. today"},{"key":"10.1016\/j.antiviral.2019.104703_bib109","doi-asserted-by":"crossref","first-page":"13923","DOI":"10.1128\/JVI.01923-14","article-title":"Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response","volume":"88","author":"Reynard","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib110","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The th1\/th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol. today"},{"key":"10.1016\/j.antiviral.2019.104703_bib111","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1128\/JVI.79.3.1487-1499.2005","article-title":"Sindbis virus translation is inhibited by a PKR\/RNase L-independent effector induced by alpha\/beta interferon priming of dendritic cells","volume":"79","author":"Ryman","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib112","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/JVI.01607-08","article-title":"Inhibition of Lassa and Marburg virus production by tetherin","volume":"83","author":"Sakuma","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib113","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1089\/107999001753124390","article-title":"Interferon-induced rat Mx proteins confer resistance to Rift Valley fever virus and other arthropod-borne viruses","volume":"21","author":"Sandrock","year":"2001","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2019.104703_bib114","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/10799900260442494","article-title":"The natural alliance between type I interferon and dendritic cells and its role in linking innate and adaptive immunity","volume":"22","author":"Santini","year":"2002","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2019.104703_bib115","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.191.10.1777","article-title":"Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice","volume":"191","author":"Santini","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.104703_bib116","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1084\/jem.178.2.567","article-title":"Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice","volume":"178","author":"Scharton","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.104703_bib117","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.4049\/jimmunol.155.5.2525","article-title":"IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice","volume":"155","author":"Schijns","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib118","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib119","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104703_bib120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.it.2015.01.002","article-title":"The molecular basis for functional plasticity in type I interferon signaling","volume":"36","author":"Schreiber","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib121","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon\u2010\u03b3: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.antiviral.2019.104703_bib122","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00482-18","article-title":"Arenaviral nucleoproteins suppress PACT-induced augmentation of RIG-I function to inhibit type I interferon production","volume":"92","author":"Shao","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128636","article-title":"Selective blockade of interferon-alpha and -beta reveals their non-redundant functions in a mouse model of West Nile virus infection","volume":"10","author":"Sheehan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2019.104703_bib124","doi-asserted-by":"crossref","first-page":"12720","DOI":"10.1128\/JVI.01471-07","article-title":"Viral encounters with 2\u2032, 5\u2032-oligoadenylate synthetase and RNase L during the interferon antiviral response","volume":"81","author":"Silverman","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib125","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2567.1998.00469.x","article-title":"Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma","volume":"93","author":"Smith","year":"1998","journal-title":"Immunology"},{"key":"10.1016\/j.antiviral.2019.104703_bib126","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib127","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/intimm\/10.11.1593","article-title":"High-level IL-12 production by human dendritic cells requires two signals","volume":"10","author":"Snijders","year":"1998","journal-title":"Int. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib128","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1084\/jem.20070176","article-title":"A subset of dendritic cells induces CD4+ T cells to produce IFN-\u03b3 by an IL-12\u2013independent but CD70-dependent mechanism in vivo","volume":"204","author":"Soares","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2019.104703_bib129","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/JVI.02012-09","article-title":"A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus","volume":"84","author":"Stabenow","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib130","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0092-8674(00)80702-3","article-title":"A novel transcription factor, T-bet, directs Th1 lineage commitment","volume":"100","author":"Szabo","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.104703_bib131","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1126\/science.288.5475.2357","article-title":"Cross talk between interferon-gamma and -alpha\/beta signaling components in caveolar membrane domains","volume":"288","author":"Takaoka","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104703_bib132","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4049\/jimmunol.174.2.609","article-title":"Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-\u03b1\u03b2 responses in T lymphocytes","volume":"174","author":"Tanabe","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib133","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1016\/j.vaccine.2008.07.011","article-title":"The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines","volume":"26","author":"Thompson","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.104703_bib134","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/eji.1830100605","article-title":"Natural killer cells are responsible for the interferon production induced in human lymphocytes by tumor cell contact","volume":"10","author":"Timonen","year":"1980","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.2001.0957","article-title":"Type I IFN modulates the immune response induced by DNA vaccination to pseudorabies virus glycoprotein C","volume":"286","author":"Tudor","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104703_bib136","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1128\/JVI.02575-10","article-title":"Marburg virus VP40 antagonizes interferon signaling in a species-specific manner","volume":"85","author":"Valmas","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib137","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1128\/JVI.01097-07","article-title":"Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin \u03b1 proteins with activated STAT1","volume":"81","author":"Valmas","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib138","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1128\/jvi.69.8.4792-4796.1995","article-title":"Antiviral defense in mice lacking both alpha\/beta and gamma interferon receptors","volume":"69","author":"van den Broek","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib139","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/107999003321532501","article-title":"The role of interferons in rotavirus infections and protection","volume":"23","author":"Vancott","year":"2003","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.antiviral.2019.104703_bib140","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/intimm\/11.2.279","article-title":"Type I IFN sets the stringency of B cell repertoire selection in the bone marrow","volume":"11","author":"Vasconcellos","year":"1999","journal-title":"Int. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib141","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1128\/JVI.00945-14","article-title":"Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara","volume":"88","author":"Volz","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib142","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.175.2.1184","article-title":"Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection","volume":"175","author":"Warfield","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib143","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cytogfr.2008.11.001","article-title":"Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis","volume":"19","author":"Weber","year":"2008","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.antiviral.2019.104703_bib144","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.vaccine.2011.12.103","article-title":"Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling","volume":"30","author":"Winkelmann","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2019.104703_bib145","doi-asserted-by":"crossref","first-page":"17006","DOI":"10.1038\/celldisc.2017.6","article-title":"Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro","volume":"3","author":"Wu","year":"2017","journal-title":"Cell discovery"},{"key":"10.1016\/j.antiviral.2019.104703_bib146","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.chom.2014.07.008","article-title":"Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1","volume":"16","author":"Xu","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2019.104703_bib147","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.4049\/jimmunol.175.11.7419","article-title":"Stat1-dependent synergistic activation of T-bet for IgG2a production during early stage of B cell activation","volume":"175","author":"Xu","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib148","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coi.2014.12.012","article-title":"Viral RNA detection by RIG-I-like receptors","volume":"32","author":"Yoneyama","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib149","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00504-19","article-title":"Infectious chikungunya virus (CHIKV) with a complete capsid deletion: a new approach for a CHIKV vaccine","volume":"93","author":"Zhang","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104703_bib150","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.4049\/jimmunol.0803214","article-title":"Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70","volume":"183","author":"Zietara","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2019.104703_bib151","series-title":"Type I and Type II Interferon-Deficient Mice: 2. Evaluating Hemorrhagic Fever Virus Vaccines","author":"Zivcec","year":"2019"},{"key":"10.1016\/j.antiviral.2019.104703_bib152","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1128\/JVI.03827-13","article-title":"Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines","volume":"88","author":"Zust","year":"2014","journal-title":"J. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:36Z","timestamp":1759062756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":152,"alternative-id":["S0166354219304747"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104703","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of mice lacking type I or both type I and type II interferon responses in research on hemorrhagic fever viruses. Part 1: Potential effects on adaptive immunity and response to vaccination","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104703"}}